Evidence map›Paper›PMID 36894961›Full record

ArticleEuropean journal of medical research2023

Seroprevalence of hepatitis C virus in Jinan, China, 2008-2020.

Mingjie Xu, Fang Liu, Qianqian Zhao, Yunying Zhou, Yuanmei Zhuang, Mingyu Ji

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of medical research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mingjie XuMedical Research & Laboratory Diagnostic Center, Jinan Central Hospital Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences, 105 Jiefang Road, Jinan, 250013, Shandong, People's Republic of China.
Fang LiuDepartment of Nephrology and Blood Purification Center, Jinan City Central Hospital Affiliated to Shandong University, Jinan, 250013, Shandong, People's Republic of China.
Qianqian ZhaoMedical Research & Laboratory Diagnostic Center, Jinan Central Hospital Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences, 105 Jiefang Road, Jinan, 250013, Shandong, People's Republic of China.
Yunying ZhouMedical Research & Laboratory Diagnostic Center, Jinan Central Hospital Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences, 105 Jiefang Road, Jinan, 250013, Shandong, People's Republic of China.
Yuanmei ZhuangMedical Research & Laboratory Diagnostic Center, Jinan Central Hospital Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences, 105 Jiefang Road, Jinan, 250013, Shandong, People's Republic of China.
Mingyu JiMedical Research & Laboratory Diagnostic Center, Jinan Central Hospital Affiliated to Shandong First Medical University and Shandong Academy of Medical Sciences, 105 Jiefang Road, Jinan, 250013, Shandong, People's Republic of China. labmedzxyy@163.com.
Shandong First Medical University · CNJinan Central Hospital · CN

Funding

Academic Promotion Programme of Shandong First Medical University 2019QL024Jinan Central Hospital 2020 High-level Subject Cultivation Program Youth Project 202007005Jinan clinical medical science and technology innovation Fund 201805066Jinan Postdoctoral Innovation Project Second-Class Funding 197249Shandong Key Research and Development Fund 2018GSF121011The second batch of science and technology plan projects of Jinan Municipal Health Commission in 2020 2020-4-19
6 · The paper itself

Abstract

backgroundThe updated estimates of hepatitis C virus (HCV) seroprevalence are critical for developing strategies to manage or eliminate HCV infection.

methodsA comprehensive study on HCV seroprevalence was conducted among 365,210 patients at Jinan Central Hospital, China, from 2008 to 2020. The patients were tested for anti-HCV, HCV core antigen, hepatitis B surface antigen, syphilis antibody, human immunodeficiency virus antigen + antibody, antihepatitis A virus IgM, and antihepatitis E virus IgM.

resultsHCV seroprevalence was 0.79% and was related to age. HCV seropositivity was lower in children (aged  < 18 years) than in adults (aged  ≥ 18 years) (0.15% vs. 0.81%). High HCV prevalence was reported in adults aged  ≥ 41 years, and HCV seropositivity in those aged 41-80 years accounted for 74.56% of all seropositive individuals. Notably, the rate of HCV-HIV coinfection was 0. HCV seroprevalence was considerably higher in patients at the Kidney Disease Unit and Dialysis Department than in those at other departments (inpatient or outpatient).

conclusionsHCV seroprevalence was lower in Jinan region but higher in patients at the Kidney Disease Unit and Dialysis Department, especially in those undergoing hemodialysis.

Indexed as

CoinfectionHepatitis BHepatitis CHIV InfectionsAdultChildChinaHepacivirusHumansPrevalenceRisk FactorsSeroepidemiologic StudiesHepatitis C virusPrevalenceSeroprevalence

Identifiers

PMID36894961
PMCPMC9997000
OpenAlexW4323810435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.